Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |